Targeted Oncology presents Expert Perspective Virtual Tumor Board, a video editorial series featuring multi-disciplinary collaboration between professionals reviewing patient cases and discussing diagnoses, biomarker testing, and treatment strategies.
November 10th 2022
In this panel discussion, experts review clinical cases of metastatic non-small cell lung cancer (mNSCLC), discuss commonly observed targetable genomic alterations, and share their perspectives on key clinical trial data that could impact treatment decision-making.
September 30th 2022
An expert panel including two hematologist-oncologists and a pathologist center discussion on patient cases to review the optimal identification and management of blastic plasmacytoid dendritic cell neoplasm.
June 30th 2022
Moshe Orenstein, MD, gives a brief overview of an exciting upcoming Targeted Oncology Virtual Tumor Board series titled "Advances in Frontline Treatment for Advanced Renal Cell Carcinoma."
June 27th 2022
Expert panelists center discussion on real-world patient cases to review key clinical trial data and approaches to the management of prostate cancer.
June 24th 2022
Expert panelists center discussion on patient cases to highlight optimal management strategies in patients with hepatocellular carcinoma.
June 10th 2022
Experts review prostate cancer clinical cases and discuss approaches to treating patients with PSMA targeted therapies.
May 25th 2022
A panel of expert oncologists review three clinical cases to highlight key clinical trial data and optimal approaches to treating patients with HER2+ breast cancer.
March 31st 2022
Experts collaborate on 3 patient scenarios to review the current treatment paradigm of graft versus host disease in the context of key clinical trial data.